Literature DB >> 17702721

Spectrum of renal pathology in hematopoietic cell transplantation: a series of 20 patients and review of the literature.

Anthony Chang1, Sangeeta Hingorani, Jolanta Kowalewska, Mary E D Flowers, Tia Aneja, Kelly D Smith, Shane M Meehan, Roberto F Nicosia, Charles E Alpers.   

Abstract

BACKGROUND AND OBJECTIVES: Hematopoietic cell transplantation is a common treatment option for a variety of hematopoietic malignancies. As a result of the use of total body irradiation and/or chemotherapeutic agents, renal dysfunction often ensues. Many pharmacologic agents, such as cyclosporine and high-intensity conditioning regimens, have been linked with thrombotic microangiopathy. In addition, an association between membranous nephropathy and graft-versus-host disease has been reported in this clinical setting. DESIGN, SETTING, PARTICIPANTS, AND MEASUREMENTS: A study of autologous and allogeneic hematopoietic cell transplantation patients with renal dysfunction was conducted to document the spectrum of renal manifestations. The pathology files at the University of Washington and University of Chicago Medical Centers were reviewed, and 20 patients with a kidney biopsy after hematopoietic cell transplantation were identified. The histologic findings were correlated with relevant clinical information.
RESULTS: A wide spectrum of renal diseases could be classified into four categories: (1) Complications related to hematopoietic cell transplantation (conditioning regimen, immunosuppression, or posttransplantation complications), (2) podocytopathy, (3) membranous nephropathy, or (4) recurrence or persistence of original hematologic disease. Pathologic diagnoses included thrombotic microangiopathy, polyoma virus nephropathy, acute kidney injury/acute tubular necrosis, acute and chronic interstitial nephritis, minimal-change disease, "tip" variant of focal segmental glomerulosclerosis, membranous nephropathy, amyloidosis, and myeloma cast nephropathy. Membranous nephropathy, minimal-change disease, and amyloidosis were common causes of severe proteinuria. Because of the conditioning regimens, posttransplantation complications, and potential nephrotoxic agents used during hematopoietic cell transplantation, it was difficult to attribute the subsequent renal dysfunction to specific factors.
CONCLUSIONS: The renal biopsy remains essential for diagnosing the underlying injury that can affect one or more compartments of the kidney in this unique clinical setting.

Entities:  

Mesh:

Year:  2007        PMID: 17702721     DOI: 10.2215/CJN.01700407

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  26 in total

1.  A case of chronic kidney disease with thrombotic microangiopathy in a hematopoietic stem cell transplant recipient.

Authors:  Kunihiro Maeda; Keisuke Suzuki; Motonori Mizutani; Hitoshi Watanabe; Norihiro Suga; Wataru Kitagawa; Naoto Miura; Kazuhiro Nishikawa; Kazuharu Uchida; Hirokazu Imai
Journal:  Clin Exp Nephrol       Date:  2010-05-15       Impact factor: 2.801

2.  Clofarabine-associated acute kidney injury in patients undergoing hematopoietic stem cell transplant.

Authors:  Camille R Petri; Peter H O'Donnell; Hongyuan Cao; Andrew S Artz; Wendy Stock; Amittha Wickrema; Marjie Hard; Koen van Besien
Journal:  Leuk Lymphoma       Date:  2014-05-27

3.  NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report.

Authors:  Howard M Shulman; Diana M Cardona; Joel K Greenson; Sangeeta Hingorani; Thomas Horn; Elisabeth Huber; Andreas Kreft; Thomas Longerich; Thomas Morton; David Myerson; Victor G Prieto; Avi Rosenberg; Nathaniel Treister; Kay Washington; Mirjana Ziemer; Steven Z Pavletic; Stephanie J Lee; Mary E D Flowers; Kirk R Schultz; Madan Jagasia; Paul J Martin; Georgia B Vogelsang; David E Kleiner
Journal:  Biol Blood Marrow Transplant       Date:  2015-01-29       Impact factor: 5.742

4.  Chronic kidney disease after autologous stem cell transplantation: analysis of a single center experience.

Authors:  QiaoYuan Wu; XiaoHong Li; YongRong Lai; ZhiGang Peng; YunHua Liao
Journal:  Int Urol Nephrol       Date:  2014-03-26       Impact factor: 2.370

5.  Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allografts.

Authors:  A B Farris; D Taheri; T Kawai; L Fazlollahi; W Wong; N Tolkoff-Rubin; T R Spitzer; A J Iafrate; F I Preffer; S A Locascio; B Sprangers; S Saidman; R N Smith; A B Cosimi; M Sykes; D H Sachs; R B Colvin
Journal:  Am J Transplant       Date:  2011-06-10       Impact factor: 8.086

6.  Renal pathology in hematopoietic cell transplant recipients: a contemporary biopsy, nephrectomy, and autopsy series.

Authors:  Brian T Brinkerhoff; Donald C Houghton; Megan L Troxell
Journal:  Mod Pathol       Date:  2016-03-25       Impact factor: 7.842

Review 7.  New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy.

Authors:  Sonata Jodele; Christopher E Dandoy; Kasiani C Myers; Javier El-Bietar; Adam Nelson; Gregory Wallace; Benjamin L Laskin
Journal:  Transfus Apher Sci       Date:  2016-04-25       Impact factor: 1.764

8.  Acquired cytoresistance in the setting of hematopoietic cell transplantation.

Authors:  Richard A Zager
Journal:  Clin J Am Soc Nephrol       Date:  2010-10-21       Impact factor: 8.237

Review 9.  Chronic kidney disease after hematopoietic stem cell transplantation.

Authors:  Eric P Cohen; Priya Pais; John E Moulder
Journal:  Semin Nephrol       Date:  2010-11       Impact factor: 5.299

Review 10.  A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury.

Authors:  Sonata Jodele; Benjamin L Laskin; Christopher E Dandoy; Kasiani C Myers; Javier El-Bietar; Stella M Davies; Jens Goebel; Bradley P Dixon
Journal:  Blood Rev       Date:  2014-11-28       Impact factor: 8.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.